Vécsei L - Search Results

1

Drug safety in acute migraine treatment.

Tajti J, Majláth Z, Szok D, Csáti A, Vécsei L. Tajti J, et al. Among authors: vecsei l. Expert Opin Drug Saf. 2015 Jun;14(6):891-909. doi: 10.1517/14740338.2015.1026325. Epub 2015 Mar 15. Expert Opin Drug Saf. 2015. PMID: 25773005 Review.

2

Ischemic heart disease induces upregulation of endothelin receptor mRNA in human coronary arteries.

Wackenfors A, Emilson M, Ingemansson R, Hortobagyi T, Szok D, Tajti J, Vecsei L, Edvinsson L, Malmsjö M. Wackenfors A, et al. Among authors: vecsei l. Eur J Pharmacol. 2004 Jan 19;484(1):103-9. doi: 10.1016/j.ejphar.2003.11.001. Eur J Pharmacol. 2004. PMID: 14729387

3

[Headache: diagnosis and treatment].

Benedek K, Tajti J, Vécsei L. Benedek K, et al. Among authors: vecsei l. Orv Hetil. 2006 Sep 17;147(37):1771-6. Orv Hetil. 2006. PMID: 17131796 Review. Hungarian.

4

[The modulatory effect of estrogen on the caudal trigeminal nucleus of the rat in an animal model of migraine].

Varga H, Párdutz A, Tajti J, Vécsei L, Schoenen J. Varga H, et al. Among authors: vecsei l. Ideggyogy Sz. 2006 Nov 20;59(11-12):389-95. Ideggyogy Sz. 2006. PMID: 17203873 Hungarian.

5

Cox-2 inhibitor attenuates NO-induced nNOS in rat caudal trigeminal nucleus.

Varga H, Pardutz A, Vamos E, Plangar I, Egyud E, Tajti J, Bari F, Vecsei L. Varga H, et al. Among authors: vecsei l. Headache. 2007 Oct;47(9):1319-25. doi: 10.1111/j.1526-4610.2006.00721.x. Headache. 2007. PMID: 17927648

6

Unaltered mRNA expression of calcitonin-like receptor and receptor activity modifying proteins in human arteries in stroke and myocardial infarction.

Eskesen K, Tajti J, Hortobágyi T, Szok D, Vécsei L, Edvinsson L. Eskesen K, et al. Among authors: vecsei l. Ideggyogy Sz. 2007 Nov 30;60(11-12):459-66. Ideggyogy Sz. 2007. PMID: 18198792

7

Effects of valproate on the dopaminergic system in mice.

Vamos E, Csati A, Vecsei L, Klivenyi P. Vamos E, et al. Among authors: vecsei l. Neurol Res. 2009 Apr;31(3):217-9. doi: 10.1179/174313208X346099. Epub 2008 Sep 3. Neurol Res. 2009. PMID: 18768113

8

Selective inhibition of cyclooxygenase-2 attenuates nitroglycerin-induced calmodulin-dependent protein kinase II alpha in rat trigeminal nucleus caudalis.

Varga H, Pardutz A, Vamos E, Bohar Z, Bago F, Tajti J, Bari F, Vecsei L. Varga H, et al. Among authors: vecsei l. Neurosci Lett. 2009 Feb 20;451(2):170-3. doi: 10.1016/j.neulet.2008.12.038. Epub 2008 Dec 25. Neurosci Lett. 2009. PMID: 19121366

9

Calcitonin gene-related peptide levels in saliva of patients with burning mouth syndrome.

Zidverc-Trajkovic J, Stanimirovic D, Obrenovic R, Tajti J, Vécsei L, Gardi J, Németh J, Mijajlovic M, Sternic N, Jankovic L. Zidverc-Trajkovic J, et al. Among authors: vecsei l. J Oral Pathol Med. 2009 Jan;38(1):29-33. doi: 10.1111/j.1600-0714.2008.00721.x. J Oral Pathol Med. 2009. PMID: 19192048

10

l-kynurenine combined with probenecid and the novel synthetic kynurenic acid derivative attenuate nitroglycerin-induced nNOS in the rat caudal trigeminal nucleus.

Vámos E, Párdutz A, Varga H, Bohár Z, Tajti J, Fülöp F, Toldi J, Vécsei L. Vámos E, et al. Among authors: vecsei l. Neuropharmacology. 2009 Sep;57(4):425-9. doi: 10.1016/j.neuropharm.2009.06.033. Epub 2009 Jul 4. Neuropharmacology. 2009. PMID: 19580819

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

699 results

Search Page